Asthma & COPD Drugs Market - Forecast 2022-2027

1
Asthma COPD Drugs MarketMarket size, Industry
outlook, Market Forecast, Demand Analysis, Market
Share, Market Report 2022-2027
Contact Venkat Reddy sales_at_industryarc.com
(1) 970-236-3677
2
Download PDF Brochure

• Asthma COPD Drugs Market size is estimated to
  reach 42.1 billion by 2027, growing at a CAGR of
  4.7 during the forecast period 2022-2027. Asthma
  COPD Drugs have the principal goal to reverse
  bronchoconstriction which is hindering the airway
  to enhance air flow in and out of the lungs.
  Bronchodilators are principal in the treatment of
  airways ailments.
• They are the backbone of the present handling of
  chronic obstructive pulmonary disease (COPD) and
  are crucial in the symptomatic handling of
  asthma, though controversies around the
  application of these medications prevail.

Inquiry Before Buying
Email sales_at_industryarc.com
3
Download PDF Brochure

• Key Takeaways
• Geographically, Europe (Asthma COPD Drugs
  Market share) accounted for the highest revenue
  share in 2021 and it is poised to dominate the
  market over the period 2022-2027 owing to the
  increasing predominance of respiratory ailments
  and extensive application of inhaled
  corticosteroids for the treatment of asthma in
  the North American region.
• Asthma COPD Drugs Market growth is being driven
  by the increasing predominance of asthma and
  chronic obstructive pulmonary disorder (COPD)
  requiring the application of anticholinergics and
  surging technological progress across the world.
  However, the raised setup cost and soaring
  maintenance are some of the major factors
  hampering the growth of Asthma COPD Drugs
  Market.

Inquiry Before Buying
Email sales_at_industryarc.com
4
Download PDF Brochure
Asthma COPD Drugs Market Segment Analysis -
By Drug Class The Asthma COPD Drugs Market
based on drug class can be further segmented into
Bronchodilators, Anti-inflammatory Drugs,
Monoclonal Antibodies, Combination Drugs. The
Combination Drugs Segment held the largest Asthma
COPD Drugs market share in 2021. This growth is
owing to the heightening application of
combination drugs attributed to the reliability
of combination therapy. Combination inhalers are
accessible for the treatment of Chronic
Obstructive Pulmonary Disorder (COPD) as per the
recommendation of the physician. When inhaled
corticosteroids (ICS) are prescribed for COPD, it
is suggested to take them with bronchodilators.
Inquiry Before Buying
Email sales_at_industryarc.com
5
Download PDF Brochure

• Asthma COPD Drugs Market Industry Outlook 
• GlaxoSmithKline PLC
• Merck Co. Inc.
• AstraZeneca PLC
• Boehringer Ingelheim GmbH
• Novartis AG

Inquiry Before Buying
Email sales_at_industryarc.com
6
Download PDF Brochure
Asthma COPD Drugs Market - Forecast(2022 -
2027) Learn More About the Report _at_
https//5mp2.short.gy/dFuJjh
Inquiry Before Buying
Email sales_at_industryarc.com
7
Download PDF Brochure

• You Can Customize the Report as Per Your Need.
  We have included Some Customization Options
• Company Profile
• Analyst Briefing
• Data Tables
• Key Contacts
• Free Customization
• Purchase Full Report _at_https//www.industryarc.com/
  purchasereport.php?id17345

Inquiry Before Buying
Email sales_at_industryarc.com
8
Download PDF Brochure
For More Details Contact Venkat
Reddy Contact (1) 970-236-3677 Email
sales_at_industryarc.com Connect with us on LinkedIn
_at_ http//www.linkedin.com/company/industryarc
Contact (1) 970-236-3677
Inquiry Before Buying
Email sales_at_industryarc.com